If your AMH has come back low, you’ve probably already heard the shorthand version of what it means. A number, a raised eyebrow from your GP, and a referral letter that reads like the decision has already been made.

You haven’t asked to skip straight to IVF. You’ve asked what a low AMH result actually tells you — and what it doesn’t.

The Number That Gets Treated Like a Verdict

AMH is treated as a measure of egg reserve — how many eggs you have left, and by extension, how much time you have. A low result gets read the same way a low bank balance would be: there’s less of something, and less time to address it.

That reading is why IVF often gets raised the moment the result comes back, sometimes before any other cause has been investigated. Fewer eggs, less time, faster treatment. The logic sounds airtight.

But there is no test for ovarian reserve. AMH is an indicator of current follicle activity — not a count of eggs remaining.

What AMH Is Actually Measuring

AMH is a hormone. It can go up as well as down.

It is released by developing follicles in the ovaries and gives an indication of how many follicles are active at that time. Because it reflects current hormonal signalling, levels can fluctuate rather than follow a fixed downward path.

AMH does not show egg quality, implantation potential, or whether pregnancy will happen.

It is one piece of information used in fertility planning, but it does not explain the wider physiological factors that influence conception.

Recent pregnancy is a documented example of that fluctuation. AMH falls through pregnancy and stays suppressed for months afterward, only returning to its prior baseline by around five months postpartum. A result drawn during that window reads lower than the underlying picture actually is.

Correcting a vitamin D deficiency is another. In women without PCOS, raising a low vitamin D level has been shown to raise AMH afterward — a low vitamin D reading can suppress what your AMH shows, and it’s correctable.

What Else Shapes the Picture

Whether a pregnancy is possible without IVF depends on ovulation, tubal patency, sperm parameters, and age — not on the AMH number. These are the factors that decide it, not the AMH result.

If any of these haven’t been checked yet, discuss it with your doctor before proceeding.  A low AMH result on its own answers none of them.

Subfertile Is Not the Same as Infertile

Subfertile means a reduced chance of conceiving that is modifiable, and is unlikely to need IVF. Infertile means unable to conceive without medical intervention — a missing or absent reproductive organ, for example.

Most medical interventions require a clinical criteria to be met before the procedure can ethically be performed. For example, an appendix is removed because specific clinical criteria have been met. There is no equivalent set of criteria for IVF, so there is no ethical barrier to the procedure. A low AMH result on its own does not make you infertile, and it does not meet any clinical criteria requiring IVF.

IVF Doesn’t Resolve Low AMH Either

IVF is not a solution for low AMH. It changes where fertilisation happens. It does not change the number or condition of the eggs a body produces.

Before considering IVF for any reason, live birth rates should be considered. IVF birth rates in the UK average 24% per embryo transfer. Low AMH lowers the number of eggs a cycle has to work with, and fewer eggs means fewer chances at each stage after retrieval — fertilisation, embryo development, transfer.

Where the Egg and Sperm Environment Still Matters

Whether you and your partner are trying naturally, moving toward IVF, or still deciding, one thing stays true regardless of what the AMH number says: the eggs maturing right now, and the sperm being produced right now, are developing inside a cellular environment shaped by what’s feeding it.

Every egg takes around ninety days to mature before it’s ready for fertilisation. Sperm follow a comparable cycle. Oxidative stress during that window disrupts the mitochondria that supply an egg’s energy for fertilisation and early division, and it damages sperm DNA in ways a standard semen analysis won’t pick up. Cortisol and insulin balance shapes how efficiently reproductive hormones get produced in the first place — for men, insulin resistance is linked to lower testosterone and reduced sperm production. None of this shows up on an AMH test. It shapes what that test can’t see.

Preparation Before Escalation

You’ve already spent time trying — tracking cycles, watching and waiting, having the AMH conversation more than once. That number doesn’t tell you what your body needs now. It tells you how many follicles were active on the day the blood was drawn. Nothing about the biological environment your eggs and your partner’s sperm are developing in right now — whichever route you take next.

I have seen too many women clutch at the IVF straw without understanding its limitations for low AMH.

The Now Baby 90-Day Nutrition Protocol for Low AMH is built around what matters for both partners as they prepare for conception. 90 days supporting the metabolic stability and nutrient density an egg and sperm need to mature — the part of this that was never on the AMH report, and isn’t answered by IVF either.

Start the Low AMH Nutrition Protocol

AMH is often one of the first fertility checks made, mainly because it is a simple blood test, taken at any time of your menstrual cycle, rather than because of its accuracy for measuring your fertility

You may be told that your egg reserve is low, time is running out or IVF should be your next step. What begins as a blood test, can quickly become used as a prediction about whether you will ever get pregnant naturally.

Understanding the function of AMH can help unravel its true role.

AMH is a hormone, it can go up as well as down and it does decline naturally with age. It is produced by follicles currently maturing eggs for ovulation, dormant follicles (ovarian reserve) do not produce AMH.

Natural conception begins with a single egg. Although multiple follicles have left dormancy and entered development, only one becomes dominant in an ovulatory cycle and the egg inside it completes maturation before release. AMH can be low or high and still only one egg will be released. The competency of that egg to be fertilized is not a function of AMH.

AMH describes activity much earlier in egg maturation process.

Where AMH has a clinical use

AMH has a specific use when an IVF clinic needs to estimate how your ovaries may respond to stimulation medication. Stimulation attempts to develop several follicles in the same cycle so that several eggs can be collected, rather than the single egg usually released during natural ovulation.

Antral follicle count, or AFC, adds a second estimate by counting the small follicles visible on an ultrasound. AMH and AFC can both predict ovarian response and the likely number of eggs collected.

Outside IVF, a low result is often interpreted to mean that few eggs remain and the opportunities for natural conception are running out. Dormant follicles do not produce AMH, so the result is not a count of the eggs remaining in your ovaries.

Low AMH may also be used to create urgency around egg freezing because fewer eggs may be collected in one stimulated cycle. That estimate concerns the number of eggs likely to be collected if you choose egg freezing. It does not establish that egg freezing is needed as an alternative to trying naturally, and ovarian reserve markers should not be used to promote planned egg freezing when fertility has not been established.

AMH can predict egg yield after ovarian stimulation — it is not the right measure to predict natural conception.

Where low AMH can affect natural conception

A low result can occur while ovulation continues regularly. When a dominant follicle develops and releases its egg, that egg can still be fertilised.

Statistically, research found there was no difference in time to pregnancy even when AMH was as low as 0.7.

When low AMH occurs alongside irregular or absent periods, both findings may reflect a reduction in the follicles developing towards ovulation. The low AMH indicates reduced activity among these developing follicles; the change in your periods shows that ovulation may also have become less frequent. Together, they can indicate fewer cycles in which an egg is released for natural conception.

Age has separate relevance because chromosome errors within the egg become more likely as eggs age.

AMH hormone production from developing follicles and the permanent end of ovarian activity are different functions.

AMH and the timing of menopause

Low AMH does not mean you are running out of eggs or predict when you will reach menopause. Menopause occurs when ovarian activity has ceased and menstrual periods have stopped permanently.

Low AMH is also different from premature ovarian insufficiency, or POI. This is a loss or disruption of ovarian activity before the age of 40. It is identified through menstrual changes and biochemical investigation rather than an AMH result alone, with current guidance defining POI through irregular or absent periods alongside biochemical confirmation of ovarian insufficiency.

When your periods remain regular, a low AMH result cannot show how many ovulatory cycles remain. What matters for natural conception now is whether ovulation is taking place and what happens to the egg and sperm before they meet.

When conception has not happened

If you have not conceived within a timeframe you are comfortable with, it is worth considering factors beyond low AMH rather than allowing one result to stand as the explanation.

AMH cannot predict whether the egg and sperm have developed the capacity required for successful fertilisation.

Both cells continue developing during the months before conception. Targeted nutrition brings the required protein, essential fats and micronutrients together with metabolic stability across this period.

Egg and sperm development before conception

The egg released at ovulation has spent months developing inside its follicle. During final maturation, it must complete chromosome division accurately so that it carries the correct number into fertilisation. It must also build enough energy to support fertilisation and the first cell divisions after conception.

Sperm develop across approximately three months. Each sperm must package its DNA, form the tail and energy system required to reach the egg, and develop the membrane needed to fuse with it.

Protein supplies amino acids used to build these cellular structures. Essential fats form part of cell membranes. Vitamins and minerals participate in energy production, chromosome organisation and DNA protection.

These resources need to remain available throughout egg and sperm development. This depends on specific nutrients, regular protein intake and essential fats, together with metabolic stability.

Preparation matters

Metabolic stability means maintaining a reliable supply of energy and nutrients while regulating blood glucose across the day. Regular nutrient intake, sufficient protein and balanced meals provide more consistent conditions for egg and sperm development.

Supplements can provide selected vitamins and minerals. They cannot supply the protein, essential fats and energy required each day or create the environment for metabolic stability.

For natural conception with low AMH, the nutritional focus is the single egg developing towards ovulation and the sperm that may fertilise it. Their capacity for fertilisation is being built during the 90 days that daily nutrition can reach.

The Now Baby 90-Day Nutrition Protocol for Low AMH gives both partners a complete 12-week protocol built around this shared development window. It brings the nutritional resources and metabolic stability required for egg and sperm development together across the full 90 days.

Start the Low AMH Nutrition Protocol

At 36, Alison had been trying to conceive for three years. Her day 3 and day 21 blood tests were fine, her partner’s semen analysis was fine and an IUI had been unsuccessful. They still had no explanation for why they were not getting pregnant.

Their usual routine did not look extreme. Alison skipped breakfast and gave little thought to including protein in their meals. Food was chosen because it was quick and easy rather than for its nutritional value. She ate no fruit, and baked beans were often as close as she came to vegetables.

There was plenty of Coke Zero, and Alison and her partner would each drink a couple of bottles of wine over the weekend.

Feeling frustrated and defeated, on the recommendation of a friend, they started the Now Baby 90-Day Nutrition Protocol for Unexplained Infertility together.

They swapped their usual tea for a naturally caffeine-free tea and replaced the Coke Zero with water. Homemade soups brought vegetables into Alison’s day without her having to think about them and replaced the shop-bought sandwiches she had relied on for lunch.

As the caffeine reduced, Alison began sleeping better.

By the end of the first month, her previously heavy periods were noticeably lighter. By the end of the second, her usual period pain had reduced so much that she did not need pain relief. Her third period brought further changes.

Alison conceived at her next ovulation.

When they wanted another baby, they returned to the same changes and succeeded again.

Alison didn’t think there was anything particularly wrong with their lifestyle.. But as she saw consistent changes to her menstrual cycle, month after month, she knew they were on the right track before the pregnancy test confirmed it.

The Now Baby 90-Day Nutrition Protocol for Unexplained Infertility is the same complete protocol Alison and her partner returned to when they wanted their second baby.

Start the Now Baby 90-Day Nutrition Protocol for Unexplained Infertility

This mama was in her mid-30s and her partner was in his early 40s. They had been trying for their second baby for 12 years.

Their son was now 13 and desperate for a brother or sister. He had spent almost his entire childhood waiting for the baby they all wanted.

Mama already had a regular eating routine. Dad’s days looked very different. He worked late, got up late and started with coffee. More caffeine carried him through most of the day until he finally ate a late dinner.

Although he was not particularly overweight, he was carrying significant visceral fat around his middle. He had no idea that his lifestyle affected their chance of having a baby and even less understanding that the belly fat might be damaging his swimmers.

They started the Now Baby 90-Day Nutrition Protocol for Unexplained Infertility together. For Dad, following the protocol meant eating at regular times instead of running on coffee until dinner.

As his eating routine became more regular, he found he needed less coffee. He began sleeping better and getting up earlier. His belly reduced too.

Within three months, this mama was pregnant.

By the time their second baby arrived, their eldest was 14. After waiting for most of his childhood, he finally welcomed the baby brother he had been so desperate for.

Although they were not starting from the same please they worked together towards their joint goal.

For Dad, that meant replacing coffee-fuelled days and one late meal with a regular eating routine he could sustain. Within weeks, he needed less caffeine, slept better, got up earlier and saw his belly reduce.

Within three months, they were pregnant with the baby they had waited 12 years for. Just because it is taking a long time doesnt mean it will never happen.

The Now Baby 90-Day Nutrition Protocol for Unexplained Infertility gives you and your partner the same complete structure to follow together, even when your daily routines—and the changes you each need to make—are very different.

Sometimes the weakest link in a couple’s fertility preparation is hiding in plain sight. More often, it is not so obvious.

The Now Baby 90-Day Nutrition Protocol for Unexplained Infertility brings both partners into one complete 90-day structure, so neither partner is left outside the preparation simply because the weakest link has not been identified.

Start The 90-Day Protocol Now

At 31, this mama had been trying for her first baby for more than 18 months.

She had completed five cycles of Clomid and experienced a miscarriage. Her infertility remained unexplained.

Both she and her husband had busy lives, both career wise and after work activities and commitments. Their diets had become more convenient than nutritious and were often eaten late at night. This is a common theme with couples struggling to get pregnant. It is never deliberate, but the body keeps score.

The 5 failed cycles of Clomid had knocked them back and the pregnancy loss even more. Diet had gotten even worse because they could see no way out of their unexplained infertility.

It was the due date of the baby she lost when she decided to take action. She knew making changes would be difficult but her husband was onboard and they pulled together to make it work. One meal at a time they were eating more protein, drinking less caffeine and timing their meals in a way that supported circadian rhythm. The first thing she noticed was better sleep, then the brown bleeding before her period stopped. 90 days passed as they felt more and more energised and less and less reactive. The third cycle was it, the two blue lines finally appeared.

Like anyone after pregnancy loss, they couldnt get too excited but by the time they saw a strong heartbeat at their 12 week scan they relaxed and accepted their unexplained infertility was behind them.

They had begun by changing one part of their fertility journey that still belonged to them: how they nourished themselves. They made that change together, followed the protocol consistently for 90 days and reached the outcome they had been working towards for more than 18 months.

The Now Baby 90-Day Nutrition Protocol for Unexplained Infertility gives you and your partner the same complete structure this couple followed, with normal supermarket foods combined into meals designed around defined fertility nutrient targets.

Start your Protocol today

Letrozole is widely associated with ovulation induction, so finding it on a frozen embryo transfer medication plan can seem unexpected. Your embryos have already been created and no eggs are being collected.

In an FET cycle, letrozole has a narrower job. Understanding that job explains why your clinic has chosen this route, what the additional medication is for and what letrozole can — and cannot — contribute to the transfer.

Why is letrozole used in a frozen embryo transfer cycle?

Before a frozen embryo can be transferred, the endometrium must develop and then receive progesterone for the correct length of time. A letrozole FET creates an ovulatory route to that transfer window.

This can provide an alternative to relying entirely on spontaneous ovulation or using a programmed cycle in which oestrogen and progesterone medication prepare the lining. The clinic can work with your ovarian response while monitoring the cycle closely enough to time the transfer.

Letrozole is being used to organise the cycle before transfer. It does not act on the frozen embryo.

How does letrozole prepare your body for embryo transfer?

Letrozole blocks aromatase, temporarily reducing oestrogen feedback so that follicle-stimulating hormone increases and encourages a follicle to develop.

As that follicle grows, your own oestrogen production rises and the endometrium develops. After ovulation, the follicle becomes the corpus luteum, which produces progesterone for the next phase of the cycle.

This distinction matters: letrozole does not build the lining by supplying oestrogen. It prompts the ovarian response that generates the hormones used in an ovulatory FET cycle. Your clinic then uses ovulation and progesterone exposure to align the endometrium with the developmental age of the embryo.

Who may be offered a letrozole FET cycle?

You may be offered letrozole if absent or irregular ovulation would make a natural FET difficult to begin or time. It is commonly considered for women with PCOS or long, irregular cycles.

Letrozole-assisted FET is also used in women who ovulate regularly. In that setting, it allows the clinic to create and monitor an ovulatory cycle rather than replacing it with a fully programmed protocol.

Your diagnosis does not decide the protocol on its own. Previous cycle response, endometrial development and the clinic’s approach to FET preparation also shape the recommendation.

What happens during a letrozole frozen embryo transfer cycle?

Letrozole is taken for a short course early in the menstrual cycle. Your clinic then uses ultrasound, and sometimes hormone tests, to follow the developing follicle and endometrium.

Once the follicle is ready, the clinic may wait for your natural luteinising hormone surge or give an hCG trigger to control when ovulation occurs. The transfer date is calculated from ovulation and any prescribed progesterone so that the endometrium reaches the correct stage for the developmental age of the embryo.

The exact tablet dose, monitoring schedule and transfer calculation vary between clinics. Follow the dates on your own treatment plan, particularly if the clinic changes them after a scan or blood test.

Why might you still need an hCG trigger or progesterone?

Each medicine has a separate job.

Letrozole supports follicle development but does not provide a precise ovulation time. An hCG trigger can give the clinic a defined point from which to schedule ovulation and transfer. If your natural hormone surge is clear and appropriately timed, a trigger may not be needed.

Because the trigger contains hCG — the hormone measured by pregnancy tests — testing before your clinic’s scheduled date may give a positive result from the injection rather than implantation. Letrozole itself does not cause a false-positive pregnancy test.

Progesterone may be prescribed after ovulation as luteal support. Its use does not mean letrozole has failed or that your body produced no progesterone. The clinic is adding support to the post-ovulation phase and controlling the progesterone exposure used to time transfer.

Does letrozole improve frozen embryo transfer success rates?

Letrozole can make an ovulatory FET cycle possible or easier to time. That is different from proving that the medicine itself makes implantation more likely.

Current evidence does not establish a higher live-birth rate with letrozole-assisted FET than with programmed endometrial preparation in women with PCOS.

The relevant measure is whether the protocol solves the problem it was selected for: creating a usable ovulation and giving the clinic a reliable transfer window. Embryo competence, accurate timing and the biology after transfer still determine whether pregnancy continues.

If your clinic recommends letrozole, ask what it is intended to achieve in your cycle. The answer should be more specific than improving your chance of success.

What are the side effects of letrozole during FET?

Letrozole is usually taken for only a few days. Possible effects during a short fertility course include hot flushes, headache, tiredness, dizziness and nausea.

More than one follicle can develop, which is one reason the ovaries are monitored during the cycle. Your clinic will tell you whether the response is appropriate for the planned transfer.

Preparing for implantation in a letrozole FET cycle

Letrozole helps your clinic establish the hormonal route to transfer. The trigger and progesterone refine its timing. Once the embryo has been transferred, implantation still has to unfold.

Implantation has 5 distinct phases and each has to complete successfully for pregnancy to continue.

The two-week wait is not a passive phase; it is biologically active. Each phase creates different nutritional and metabolic requirements as implantation progresses.

The Now Baby FET Implantation Support Meal Plan translates those changing requirements into 14 days of precisely structured, professionally measured nutrition. Every ingredient, quantity and meal is designed around the biological demands of the implantation process.

Your nutritional support for implantation is measured, planned and ready for when implantation is beginning.

Get the FET Implantation Support Meal Plan

You may have reached egg collection expecting the next step to be a fresh embryo transfer. Instead, you developed OHSS and your clinic cancelled the transfer. If an embryo implanted, the resulting rise in hCG could intensify the ovarian swelling and fluid shifts already caused by OHSS, allowing a manageable complication to become medically dangerous. Cancelling the fresh transfer removes that pregnancy-driven risk while your body recovers.

Egg collection, fertilisation and embryo development follow the same process whether the transfer is fresh or frozen. The difference now is instead of having a fresh transfer as part of this cycle, embryos that meet your clinic’s usual freezing criteria are frozen instead.

Once you have recovered and it is medically safe to proceed, transfer takes place in a separate frozen embryo transfer cycle. Your womb lining is prepared before an embryo is thawed and transferred.

Why Was Your Fresh Embryo Transfer Cancelled Due to OHSS?

OHSS develops when the ovaries respond excessively to the stimulation medicines used before egg collection. The ovaries become enlarged and release substances that make blood vessels more permeable, allowing fluid to leave the bloodstream and collect in the abdomen and, in more severe cases, around the lungs.

The hCG trigger used before egg collection can start this process. If a fresh embryo transfer resulted in pregnancy, the developing pregnancy would produce more hCG. This could intensify the ovarian swelling and fluid shifts, prolong the OHSS and increase the risk of serious complications including breathing difficulties, blood clots and reduced kidney function.

Pregnancies affected by OHSS are also associated with a higher risk of pre-eclampsia and premature birth. Cancelling the fresh transfer therefore protects both you and a potential pregnancy. It removes the risk of pregnancy continuing to drive the OHSS while your ovaries recover and your fluid balance returns to normal.

What Happens to Your Embryos After the Transfer Is Cancelled?

Cancelling your fresh transfer does not stop fertilisation or embryo development. Your embryology team continues to monitor the embryos in the laboratory, just as it would during a fresh-transfer cycle.

The difference comes when an embryo would usually be selected for transfer. Because no embryo can be placed into your womb while you have OHSS, the clinic freezes the embryos that meet its usual freezing criteria. These criteria apply to every embryo being considered for freezing.

The number frozen will depend on how many fertilised eggs continue developing and reach the stage and quality required by your laboratory. Your clinic should tell you how many embryos were frozen, the day each was frozen and its grade.

The embryos then remain in storage while you recover. They are not continuing to develop during this time: freezing pauses their biological activity until one is thawed for a later frozen embryo transfer.

What Happens to Your Body After Egg Collection and OHSS?

After egg collection, your ovaries remain enlarged and the blood vessels may continue leaking fluid into your abdomen. This can cause bloating, abdominal pain, nausea, rapid weight gain and reduced urine output. More severe fluid shifts can affect your breathing, circulation and kidney function.

Your clinic may monitor your weight, abdominal swelling, urine output, blood tests and symptoms. Treatment depends on the severity of the OHSS and may include fluids, medication to reduce the risk of blood clots, drainage of fluid from the abdomen or hospital care.

Without a pregnancy producing further hCG, OHSS usually begins to settle as the trigger medication leaves your body. Your ovaries gradually reduce in size, the fluid moves back into the bloodstream and your kidneys remove it through urine. A cancelled transfer reduces the risk of OHSS being prolonged by pregnancy, but you still need monitoring until the complication has resolved.

When Can You Have a Frozen Embryo Transfer After OHSS?

Your frozen embryo transfer will not be scheduled until the OHSS has resolved and your ovaries and fluid balance have returned to baseline. This usually means allowing the egg-collection cycle to end and waiting for at least one period before beginning an FET cycle.

The exact timing depends on the severity of the OHSS, how quickly your body recovers and the type of frozen transfer cycle your clinic recommends. Mild OHSS may settle within a couple of weeks, while more severe OHSS can delay treatment for longer.

Waiting does not change the time your embryos spend developing. Once frozen, their biological activity is paused until an embryo is thawed for transfer. The delay allows the effects of ovarian stimulation to settle so the transfer can take place in a separate cycle prepared for implantation.

Does a Freeze-All Cycle Affect Your Chance of Success?

Your chance of a live birth from this egg collection is best assessed across all the embryos transferred from it. This is the cumulative live birth rate, rather than the outcome of the first transfer alone.

Research comparing freeze-all cycles with cycles that begin with a fresh transfer has found little or no difference in cumulative live birth rates. The embryos are transferred later, after your body has recovered from ovarian stimulation and OHSS.

The frozen pathway introduces a freezing and thawing stage before transfer. Your individual outcome therefore depends on how many embryos are frozen, whether an embryo survives thawing and what happens during each frozen embryo transfer. The change from fresh to frozen primarily changes the timing and process, rather than lowering the overall chance from the egg collection.

Supporting Implantation After Your Frozen Embryo Transfer

OHSS changed your route from egg collection to embryo transfer. Once you have recovered and your frozen transfer goes ahead, the focus moves firmly towards what happens next.

Embryo transfer is the clinical procedure. Implantation is the biological process that must follow.

Implantation has 5 distinct phases and each has to complete successfully for pregnancy to continue.

The two-week wait is not a passive phase; it is biologically active. Each phase creates different nutritional and metabolic requirements as implantation progresses.

The Now Baby FET Implantation Support Meal Plan translates those changing requirements into 14 days of precisely structured, professionally measured nutrition. Every ingredient, quantity and meal is designed around the biological demands of the implantation process.

Your nutritional support for implantation is measured, planned and ready for when implantation is beginning.

Get the FET Implantation Support Meal Plan

You can look at one IVF success rate and see a low percentage per egg collected, then look at another and see a much higher percentage per embryo transfer. It can feel as though one of them must be wrong.

Usually, neither is.

Each percentage starts counting at a different point. A live birth rate per egg retrieved begins with every egg collected. A live birth rate per egg collection looks at the whole collection procedure. A live birth rate per embryo transfer begins later, once an embryo has already reached transfer.

That difference matters because an egg still has to fertilise, develop and become suitable for transfer before pregnancy can begin. A percentage measured from embryo transfer leaves those earlier stages outside the calculation.

Once you can see where each percentage begins, the figures stop contradicting each other. They start answering different questions.

The three IVF success rates are measuring different things

A live birth rate per egg retrieved starts with each individual egg collected. It follows that egg through fertilisation, embryo development, transfer, implantation and pregnancy.

A live birth rate per egg collection starts with the retrieval procedure as a whole. It looks at whether that collection eventually led to a live birth, sometimes including more than one embryo transfer from the same group of eggs.

A live birth rate per embryo transfer starts much later. It includes only embryos that developed far enough to be transferred.

This is why the percentage per embryo transfer is usually higher. It begins after several earlier stages have already been completed. The percentage per egg retrieved begins before any of them have happened.

What live birth rate per egg retrieved means

A live birth rate per egg retrieved starts with every egg collected during retrieval.

It then follows each egg through every stage that comes after: fertilisation, embryo development, transfer, implantation and pregnancy.

That is why this percentage is much lower than the live birth rate per embryo transfer. It includes eggs that do not fertilise, embryos that stop developing and embryos that never reach transfer.

The figure also changes with age. A percentage that may be reasonable for one age group can be far too high for another.

So an average of around 8% per egg retrieved may be useful in a worked example, but it should not be read as your personal chance from each egg.

What live birth rate per egg collection means

A live birth rate per egg collection starts with the retrieval procedure, rather than with each individual egg.

It asks whether that collection led to a live birth.

The important detail is whether the figure includes only the first embryo transfer or all fresh and frozen transfers created from that collection.

When all transfers are included, the result is a cumulative live birth rate per egg collection. This gives a fuller picture of what one retrieval produced overall.

So before comparing clinic figures, check whether the percentage is based on the first transfer only or on every transfer from the same collection. They are not measuring the same thing.

What live birth rate per embryo transfer means

A live birth rate per embryo transfer starts with the embryo placed in the uterus.

It does not include the eggs that did not fertilise or the embryos that did not develop far enough to be transferred.

That is why this percentage is higher than the live birth rate per egg retrieved. It begins later, after several earlier stages have already been completed.

It can be useful when you want to know what happened once an embryo reached transfer. It cannot tell you what one egg collection produced overall.

One egg collection can produce three different success rates

Take one simplified example:

• 8% live birth rate per egg retrieved
• 40% cumulative live birth rate per egg collection
• 30% live birth rate per embryo transfer

These percentages are describing the same IVF pathway from different starting points.

The 8% begins with every egg retrieved.

The 30% begins only when an embryo reaches transfer.

The 40% looks at the egg collection as a whole and includes the chance of a live birth across all the embryos transferred from it.

That percentage can be higher than the rate per embryo transfer because one egg collection may produce more than one opportunity for transfer.

The figures have not changed because the treatment became more or less successful. The percentage changes because the starting point changes.

After a failed first transfer, it can feel as though the odds have already moved against you.

They have not automatically changed because this is your second attempt.

Here, a failed transfer means that the pregnancy test was negative. A biochemical pregnancy or miscarriage confirms that implantation began and needs to be understood as pregnancy loss rather than failed implantation.

In 2023 UK data, the average live birth rate was 33% per frozen embryo transferred. Approximately two out of every three frozen embryo transfers did not result in a live birth.

Your first result belongs within that wider reality. The chance attached to your next FET will depend on the embryo being transferred and the conditions in which it attempts to implant.

Does One Failed Embryo Transfer Reduce Your Chances Next Time?

One negative pregnancy test cannot establish why the transfer did not work.

If the embryo was untested, a chromosome error may have prevented development from continuing. A highly graded embryo can still have a chromosome error because grading assesses appearance and developmental progress, not chromosome number.

A euploid PGT-A result reduces that particular uncertainty, but euploid embryos do not produce a live birth after every transfer. Chromosome screening cannot assess every part of embryo development or complete implantation on the embryo’s behalf.

After transfer, the embryo must continue developing while communicating with the uterine lining. Attachment, invasion, changes to the maternal blood supply, immune adaptation and early placental formation must follow in sequence.

A negative pregnancy test cannot show whether the embryo did not attach or whether development stopped before hCG reached a detectable level.

The transfer result tells you what happened. It does not tell you why.

Second Embryo Transfer Success Rates

Published second-transfer rates are difficult to compare because “second transfer” does not always describe the same treatment stage.

If your first transfer was fresh and your next will be frozen, this is your second embryo transfer overall but your first FET. Research reporting outcomes for a second FET may be describing a woman who has already had one fresh transfer and one frozen transfer.

Studies also measure different outcomes. A positive pregnancy test, clinical pregnancy, ongoing pregnancy and live birth are not interchangeable measures of success.

A 2024 study followed fresh transfers and subsequent frozen transfers using embryos from the same egg-collection cohort. The predicted positive pregnancy rates were:

• 32.8% for the first FET
• 30.8% for the second FET
• 28.9% for the third FET
• 27.1% for the fourth FET

These were positive pregnancy-test rates rather than live-birth rates. The study also involved a specific group of women and embryos, so the percentages cannot predict your result.

What they show is that meaningful pregnancy rates continued across later transfers. The chance reduced gradually rather than disappearing after the first FET.

Your clinic’s live-birth rate for embryos comparable with yours will give you a more relevant estimate. Ask whether its figure matches your embryo stage, PGT-A status, age at egg collection and intended FET protocol.

Why Success Rates Can Change Across Subsequent Transfers

Clinics usually transfer the embryo with the strongest stage and grade first.

If that transfer does not result in pregnancy, the next embryo may have a lower grade or may have reached the blastocyst stage later. The difference between first and subsequent transfer rates can therefore reflect differences between the embryos available.

Grading still cannot determine the fate of an individual embryo. Lower-graded embryos can result in live births, while highly graded embryos can produce negative pregnancy tests.

Does It Matter Whether Your First Transfer Was Fresh or Frozen?

A fresh transfer takes place within the stimulated egg-collection cycle. The ovaries have produced higher hormone concentrations, and the endometrium has developed within that hormonal environment.

A frozen embryo transfer takes place in a later cycle. The lining may be prepared through your own ovulation or with prescribed oestrogen and progesterone.

Moving to FET separates the next transfer from ovarian stimulation. This may be clinically useful, but it does not make every frozen transfer more successful than every fresh transfer. The embryo, reason for freezing and method of preparing the lining still matter.

In the 2024 same-cohort study, a negative pregnancy test after fresh transfer did not predict the result of the next frozen transfer.

For a woman moving from a failed fresh transfer to FET, that is the relevant finding: the fresh result did not establish the outcome of the remaining frozen embryos.

What Your First Transfer Can Tell Your Clinic

Your first transfer may provide information that helps your clinic plan the next one.

The review should cover:

• The stage, grade and PGT-A status of the embryo transferred
• Endometrial thickness and appearance
• Progesterone timing, dose and route
• Any progesterone blood result used by your clinic
• Missed, delayed or uncertain medication doses
• Whether the procedure was straightforward or technically difficult
• Catheter placement, blood, mucus or a retained embryo
• Previous findings involving the uterine cavity

A difficult procedure may change how the next transfer is planned. A medication or progesterone issue may justify an adjustment. A uterine-cavity concern may need further assessment.

Where the lining, medication and procedure progressed as intended, there may be no clinical reason to redesign the protocol.

A change is useful when it answers something found in the first cycle. Changing the plan simply because the result was negative can create more intervention without resolving the source of failure.

Do You Need More Tests After One Failed Embryo Transfer?

One failed transfer does not automatically justify extensive testing.

Further assessment may be appropriate when the first cycle revealed a specific concern, such as a difficult procedure, persistent lining difficulty, unexpected bleeding or a suspected uterine-cavity finding.

ERA, EMMA, ALICE, immune testing, natural killer cell testing and clotting panels are frequently offered after unsuccessful transfers. Current evidence does not support routine use after one failed transfer, and finding a difference on a test does not necessarily lead to an intervention proven to increase live birth.

The HFEA add-on reviews examine the evidence for these tests individually. They can help you separate an investigation prompted by your medical history from an add-on offered because the transfer was unsuccessful.

When More Than One Failed Transfer Changes the Clinical Picture

Repeated failure carries more weight when the embryos transferred had a higher expected chance of implantation.

Three failed euploid blastocyst transfers provide different clinical information from three failed transfers involving untested embryos. Age at egg collection, embryo stage and grading also affect what can be concluded from the number of attempts.

Current professional guidance therefore considers the expected implantation potential already transferred rather than relying on one fixed number of failures for every woman.

Once enough embryos with meaningful expected potential have been transferred without detectable implantation, a broader clinical review becomes more reasonable.

Per-Transfer and Cumulative Success Rates Measure Different Things

A per-transfer live-birth rate describes the outcome of one embryo transfer.

A cumulative live-birth rate describes the chance of at least one live birth after several transfers, or after all suitable embryos from one egg collection have been used.

The per-transfer rate is more relevant to the FET you are planning now. The cumulative rate helps explain what a group of stored embryos may offer over time.

In the 2024 same-cohort study, cumulative live birth reached 57% after the fresh transfer and up to three subsequent FETs. No individual transfer carried a 57% live-birth rate. The figure came from several opportunities combined.

This is why clinic statistics may look substantially higher when reported per egg collection rather than per embryo transferred.

Before using a published figure, check whether it measures:

• Pregnancy or live birth
• One transfer or several
• One embryo or an entire embryo cohort
• Fresh, frozen or combined treatment
• Untested or PGT-A-tested embryos

The number only becomes useful once you know what outcome and treatment period it represents.

What Will Shape the Success Rate of Your Next FET?

The embryo being transferred carries its own developmental potential.

Its age-related chromosome risk is linked to your age when the egg was collected. Its stage, grade, day of blastocyst development and PGT-A status provide further information, although none can determine the outcome alone.

The next FET must then establish the clinical conditions in which that embryo will attempt to implant:

• The uterine cavity
• Endometrial development
• Progesterone timing and exposure
• Embryo survival and development after warming
• The transfer procedure

These factors bring the embryo and endometrium to the point of transfer.

A success rate can estimate what may happen next. The implantation phase determines what happens next.

Supporting Implantation After Your Next Transfer

Implantation has 5 distinct phases and each has to complete successfully for pregnancy to continue.

Each phase has its own nutritional requirements.

Rapid cell division requires energy and the raw materials needed to copy DNA, build proteins and form cell membranes. Amino acids contribute to new tissue. Fatty acids are used in cell membranes and cellular communication. Vitamins and minerals participate in DNA synthesis, methylation, antioxidant defence, immune adaptation and early vascular development.

Metabolic stability matters because these processes need a consistent supply of energy and nutrients while implantation progresses. Supplements cannot offer this level of support.

Your clinic manages the embryo transfer with Precision. You should do the same with your nutrition for this critical phase.

The Now Baby FET Implantation Support Meal Plan has taken all of the guesswork out for you. The nutrients needed for the full implantation phase have been professionally curated into a plan that is easily implemented.

Get the FET Implantation Support Meal Plan.

You may have one embryo that reached the blastocyst stage on Day 5 and another that reached it on Day 6. If your clinic has placed the Day 5 blastocyst first on your transfer list, the difference of a single day can feel like a verdict on which embryo is more likely to become your baby.

It isn’t that simple.

Day 5 and Day 6 state when each embryo reached the blastocyst stage. Day 5 blastocysts generally have higher success rates across large groups, but development speed is only one part of an individual embryo’s transfer priority. PGT-A result, embryo grade, whether the transfer is fresh or frozen and your clinic’s own laboratory data can all change the comparison.

If you have embryos from both days, the decision is not whether Day 5 is always better than Day 6. It is which of your embryos has the strongest combination of features for transfer first.

What Day 5 and Day 6 Blastocyst Status Actually Means

The day refers to how long the embryo took to develop from fertilisation to the blastocyst stage.

A Day 5 blastocyst reached the stage required for transfer, freezing or biopsy five days after fertilisation. A Day 6 blastocyst reached that stage one day later. Both completed the same developmental transition, but at different speeds.

During this transition, the embryo develops a fluid-filled cavity and two distinct groups of cells. The inner cell mass will form the baby, while the trophectoderm will contribute to the placenta. The blastocyst must also expand and begin preparing to hatch from its outer shell before implantation can begin.

Reaching the blastocyst stage on Day 6 does not mean the embryo stopped developing or developed incorrectly. It means it needed more time to reach the point at which your clinic could assess, freeze, biopsy or transfer it. That extra day may carry information about developmental potential, but it does not determine the outcome on its own.

Do Day 5 Blastocysts Have Higher Success Rates Than Day 6 Blastocysts?

Across large groups of transfers, Day 5 blastocysts generally have higher implantation, clinical pregnancy and live birth rates than Day 6 blastocysts.

That difference does not mean every Day 5 embryo has greater potential than every Day 6 embryo. The figures combine embryos with different grades, chromosome results, freezing methods and transfer circumstances. They describe what happened across a population rather than predict the outcome of either embryo in front of you.

Implantation rate is usually calculated from the number of gestational sacs seen on ultrasound relative to the number of embryos transferred. Clinical pregnancy rate reports how many cycles or transfers resulted in a pregnancy confirmed on ultrasound. Live birth is the outcome that shows how many transfers resulted in a baby, so it carries more weight when comparing success rates.

Development on Day 5 is therefore a favourable feature, but not a complete transfer decision. A Day 6 blastocyst may still be the stronger embryo once its PGT-A result and grade are considered.

Why Blastocyst Development Speed May Affect Transfer Priority

Day 5 blastocysts are often placed ahead of otherwise comparable Day 6 blastocysts because transfers of Day 5 embryos have produced higher live birth rates across large study populations.

The research shows an association. It has not established that reaching the blastocyst stage on Day 5 causes the higher live birth rate or that taking until Day 6 makes an individual embryo biologically inferior.

Development day may be connected with other differences between the embryos being compared. Day 5 blastocysts are more likely, as a group, to be euploid and may also differ in grade. Laboratory procedures, embryo selection and whether the embryos were transferred fresh or frozen can influence the outcomes recorded in each group.

Development day can help estimate which embryo may have the higher chance of success, but it does not explain why one embryo will or will not result in a live birth. If two blastocysts have the same PGT-A result and a comparable grade, the population-level advantage associated with Day 5 development may be used as a practical reason to transfer that embryo first.

Day 5 vs Day 6 Success Rates When Both Embryos Are Euploid

PGT-A changes the comparison because both embryos have been reported to contain the expected number of chromosomes in the cells sampled. This removes one major reason untested Day 5 and Day 6 groups may have different success rates.

Individual studies have reported mixed results. However, the latest meta-analysis found higher clinical pregnancy and live birth rates after transfer of PGT-A-tested Day 5 blastocysts than Day 6 blastocysts. Because the studies were observational, this shows an association rather than proving that reaching blastocyst on Day 5 causes the better outcome.

This uncertainty matters when your embryos are being ranked. A Day 5 euploid blastocyst may still be prioritised when both embryos have a comparable grade because it belongs to the group associated with higher live birth rates in the pooled evidence. That is a population-based transfer decision, not proof that your Day 5 embryo is biologically stronger than your Day 6 embryo.

PGT-A result and embryo grade therefore need to remain part of the comparison. Day 5 status can help separate two otherwise similar euploid embryos, but it cannot determine which individual embryo will become a baby.

Does Embryo Grade Matter More Than Day 5 or Day 6?

Embryo grade and development day measure different features.

Day 5 or Day 6 records when the embryo reached the blastocyst stage. The grade describes how expanded the blastocyst was and how the inner cell mass and trophectoderm appeared under the microscope at the time of assessment.

Neither can identify with certainty which embryo will result in a live birth. Both are associated with transfer outcomes across large groups, but neither provides a direct measurement of everything happening inside the embryo.

There is no universal rule that grade always matters more than development day. Clinics may rank the same embryos differently because grading is subjective, laboratory protocols vary and studies have not established one transfer order for every combination of day and grade.

The comparison is simplest when both embryos have the same PGT-A result and a similar grade. Day 5 status may then be used to decide which embryo is transferred first. When a higher-graded Day 6 embryo is being compared with a lower-graded Day 5 embryo, the priority is less straightforward and should be based on the clinic’s complete ranking criteria rather than either feature alone.

A Lower-Grade Day 5 Embryo vs a Higher-Grade Day 6 Embryo

This is where a simple preference for Day 5 blastocysts stops being enough.

A lower-grade Day 5 embryo reached the blastocyst stage sooner, but its inner cell mass, trophectoderm or degree of expansion received a less favourable assessment. A higher-grade Day 6 embryo took another day to reach the blastocyst stage, but its visible structure appeared stronger when it was graded.

If both embryos have the same PGT-A result, your clinic must decide how much weight to give each feature. Some laboratories may prioritise the higher-grade Day 6 embryo. Others may place greater weight on Day 5 development, particularly when the difference in grade is small.

The grading system cannot settle this comparison on its own. Embryo grading is a visual assessment, and the same embryo may not receive an identical grade from every embryologist or laboratory. Development day is recorded more objectively, but it is still associated with outcomes across groups rather than proving the potential of your individual embryo.

Ask your clinic which embryo it recommends transferring first, what feature determined that order and whether the recommendation is supported by its own live birth outcomes for comparable embryos. That gives you the reasoning behind the ranking rather than a decision based on Day 5, Day 6 or embryo grade in isolation.

Why Fresh and Frozen Transfer Data Can Give Different Answers

A Day 6 blastocyst transferred during the egg collection cycle reaches the uterus later than a Day 5 blastocyst. By then, the endometrium has also had an additional day of exposure to progesterone and may be moving beyond the most receptive part of the implantation window.

This means lower success rates after fresh Day 6 transfer cannot automatically be attributed to the embryo. They may also reflect the timing between the embryo and the endometrium.

Frozen transfer separates the embryo transfer from the egg collection cycle. In most frozen transfer protocols, Day 5 and Day 6 blastocysts are transferred after the same duration of progesterone exposure.

For that reason, fresh and frozen transfer results should not be combined as though they are measuring the same circumstances. Frozen transfer data provide a clearer comparison of Day 5 and Day 6 embryos because the lining can be prepared to receive each embryo at the intended point in the transfer cycle. Even then, differences in PGT-A result, embryo grade and laboratory practice remain.

What a Day 6 Blastocyst Means When It Is Your Best or Only Embryo

If your Day 6 blastocyst is the highest-ranked embryo you have, the comparison with Day 5 statistics no longer determines which embryo should be transferred first. Your decision is whether to proceed with this embryo or consider creating more embryos before transfer.

Its chance of success should be estimated from its own PGT-A result, grade and your clinic’s outcomes with comparable Day 6 blastocysts. A lower average live birth rate across all Day 6 transfers cannot tell you whether this individual embryo will implant.

Your age when the egg was collected may affect the likelihood that an untested Day 6 embryo is euploid. If it has already received a euploid PGT-A result, that removes much of the age-related chromosome uncertainty from the transfer decision.

A Day 6 blastocyst has completed the development required to be selected for freezing or transfer. Its status provides useful context for estimating success, but it is not a reason to dismiss an embryo that may still result in a live birth.

Once this is the embryo being transferred, the focus moves beyond how long it took to reach the blastocyst stage. Day 6 describes its development before transfer. Implantation follows transfer, and while your blastocyst development stage is currently fixed, there is ample opportunity to support what happens next.

Once the Embryo Is Chosen, Implantation Still Has to Unfold

Implantation has 5 distinct phases and each has to complete successfully for pregnancy to continue.